Top 10 Books about Stock Investing to read in 2018. Read more.

INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

INFI - Infinity Pharmaceuticals

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ
#1861()/6711

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE 2.21%
PRICE $1.85
VOLUME
Sell
TREND
Hold

MV LONG
Sell

MV SHORT
Buy

PIVOT
Buy

MACD
Sell

Request Prediction
0.00%
Predict

Infinity Pharmaceuticals Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 3.76% ( 2018-01-31 )
Cash 289.3 mill
Loans 39.1 mill
Beta 2.79
ROA -51.55
Buy candidate since 2018-02-23

Infinity Pharmaceuticals gained 2.21% in the last trading day, rising from $1.81 to $1.85 The price has fallen in 7 of the last 10 days and is down by -6.09% for this period. Volume fell in the last day by -30 154 shares, and in total, 398 874 shares bought and sold for approximately $737 917. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Access today's Top 5 Buy Candidates

Trend

Given the current horizontal trend you can expect Infinity Pharmaceuticals with 90% probability to be traded between $1.73 and $2.35 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Thursday February 22, 2018, which indicates further gains until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Infinity Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.01. On a fall, the stock will find some support from the short-term average at $1.85. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 35 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Infinity Pharmaceuticals finds support from accumulated volume at $1.82. On the upside the stock meets some resistance just above today's level from accumulated volume at $1.87, $1.98 and $1.99.

The stock is about to test the resistance from accumulated volume at $1.87 and this may cause the stock to take a minor break or get into a more sideways move for a few days.

Support: $1.82 Price: $1.85 Resistance: $1.87

Risk

This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.14 between high and low, or 8.14%. For the last week the stock has had a daily average volatility of 5.79%.

Our recommended stoploss: $1.75 (-5.62%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

Overall risk:

Very Low Low Medium High Very High

Evaluation

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for this stock to perform well in the short-term period. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Buy Candidate.

Trade INFI CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now
Help us IMPROVE our CHARTS HERE.

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features

START FREE 5-DAY TRIAL